Skip to main content
S 368 100th Congress Senate

Prescription Drug Marketing Act of 1987

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs in the United States, to place restrictions on drug samples, to ban … Show full official titleShow less

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs in the United States, to place restrictions on drug samples, to ban certain resales of drugs purchased by hospitals and other health care facilities, and for other purposes.

Introduced: July 7, 1987 See on congress.gov
Health Consumer educationConsumer protectionDrug industryDrug safety and regulation
More subjectsShow fewer subjects
DrugsDrugs and narcoticsForeign Trade and International FinanceForeign Trade and InvestmentsGovernment paperworkGovernment records, documents, and informationImport restrictionsImportsLicenses
Sign in to write a letter Sign in to watch
This bill died when the 100th Congress ended
It never became law before the 100th Congress (1987–1988) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 15, 1987
Subcommittee on International Trade. Hearings held.
Jan 21, 1987
Read twice and referred to the Committee on Finance.
Jan 21, 1987
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 15, 1987

Subcommittee on International Trade. Hearings held.

 Plain-English summary Congressional Research Service

Prescription Drug Marketing Act of 1987 - Amends the Federal Food, Drug, and Cosmetic Act to permit only the U.S. manufacturer of a drug to reimport such drug into the United States.

Prohibits the sale of prescription drug samples. Permits the distribution of samples only to practitioners licensed to prescribe such drugs. Requires such practitioners to return a receipt for such drug samples to the manufacturers to be kept and made available to Federal and State officials.

Requires drug wholesalers to provide drug purchasers with a statement identifying the manufacturer and each sale of the drug. Directs the Secretary of Health and Human Services to issue licensing standards for drug wholesalers.

Sets forth criminal penalties for violations of this Act.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Republican 2
R
Grassley, Chuck
Iowa · Jul 7, 1987
 R
McConnell, Mitch
Kentucky · Jan 21, 1987
Cite this page click to expand
APA
U.S. Congress. (2026). S. 368: Prescription Drug Marketing Act of 1987. 100th Congress. Open America. https://openamerica.io/bill/100-S-368/
MLA
"S. 368: Prescription Drug Marketing Act of 1987." 100th Congress, 2026, Open America, https://openamerica.io/bill/100-S-368/.
Bluebook (legal)
S. 368, 100th Cong. (2026), https://openamerica.io/bill/100-S-368/.
Markdown link
[S. 368: Prescription Drug Marketing Act of 1987](https://openamerica.io/bill/100-S-368/)
Report a problem